Researchers collect blood from Low-Platelet patients to uncover clues
NCT ID NCT06824727
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study collected one blood sample from 40 adults with very low platelets (30,000 or fewer per microliter) due to blood cancers or their treatments. The goal was simply to gather samples for research, not to test any new drug or therapy. Participants had to be 18 or older and could not have had recent chemotherapy or blood thinners.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help researchers learn more about low platelet counts in blood cancer patients, potentially guiding future studies.
- What could go wrong
- This is a small, completed sample collection study with no treatment tested. It does not directly benefit participants and may not lead to any new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Cleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Frailty check may steer safer cancer care for seniors
- Could gratitude exercises aid blood cancer recovery?
- Can a new tracer light up cancer growth?
- Could a platelet-boosting drug shorten recovery after stem cell transplants?
- Could a walk a day keep brain fog away after a stem cell transplant?